The magnitude of TFEB-mediated hepatic TG reduction was attenuated but not fully abolished upon MAT1A knockdown (Fig. 5n, Supplementary Fig. 7g), which is expected since TFEB is known to lower hepatic steatosis via other mechanisms23. The gene discussed is MAT1A; the disease is Hepatic steatosis.